The tirzepatide vial itself should remain at room temperature during reconstitution
Novo Nordisk submitted an NDA (new drug application) to the FDA on December 18, 2025, which is the formal step companies take when seeking approval for a medication to be marketed for public use
By following your treatment plan and embracing a healthy lifestyle, you can experience an impressive transformation
The combination of these two medicines has led to significant weight loss and improved glycemic control in adults with obesity or overweight during clinical trials
Branded Mounjaro and Zepbound pens are fixed-dose products
The clinical profile that responds best Patients in their late 30s through 60s who report declining sleep quality, reduced energy that is not explained by obvious lifestyle factors, a sense of slower recovery from physical activity or illness, and a general interest in longevity and cellular health represent the core Epithalon population at Perfect B